Correction: Real-world prevalence of microsatellite instability testing and related status in women with advanced endometrial cancer in Europe

Arch Gynecol Obstet. 2024 Oct;310(4):2281. doi: 10.1007/s00404-024-07620-0.

Authors

Sneha S Kelkar¹, Vimalanand S Prabhu², Jingchuan Zhang³, Yoscar M Ogando¹, Kyle Roney¹, Rishi P Verma¹, Nicola Miles⁴, Christian Marth⁵

Affiliations

¹ OPEN Health, Bethesda, MD, USA.
² Merck & Co., Inc., 126 East Lincoln Ave, P.O. Box 2000, Rahway, NJ, 07065, USA. [email protected].
³ Eisai Inc., Nutley, NJ, USA.
⁴ M3 (EU) Ltd., Abingdon, UK.
⁵ Department of Obstetrics and Gynecology, Medical University Innsbruck, Innsbruck, Austria.

No abstract available

Publication types

Published Erratum